|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ross Bathgate, Laboratory Head, Neuropeptide Receptor Laboratory, Howard Florey Institute
|
|
|
|
Paola Casarosa, Lab head, Post Development R&D Bronchodilators, Boehringer-Ingelheim Pharma
|
|
|
|
Rafael Franco, Professor, Department of Biochemistry and Molecular Biology, University of Barcelona
|
|
|
|
Steve Garland, Group Leader Lead Generation GSK
|
|
|
|
David Gloriam, Department of Medicinal Chemistry, Copenhagen University
|
|
|
|
Danilo Guerini, Department of BioChemistry, Novartis
|
|
|
|
Mike Hanson, Associate Director Structural Biology, Receptos
|
|
|
|
Robert Lane, Post Docutoral Fellow, Faculty of Science, Leiden/Amsterdam Center for Drug Research, Medicinal Chemistry, Univeristy of Leiden
|
|
|
|
Craig Lindsley, Associate Professor of Pharmacology and Chemistry, Director of Medicial Chemistry, Vanderbilt University Medical Center
|
|
|
|
Jonathon Mason, Head of Computational Chemistry, Heptares Therapeutics, UK & Chief Scientist, Medicinal Chemistry, Lundbeck Research, DK
|
|
|
|
Jean Mazella, Lab Head, Institut de Pharmacologie Moleculaire et Cellulaire CNRS, University of Nice-Sophia Antipolis, France
|
|
|
|
Graeme Milligan, Professor or Molecular Pharmacology; Joint Research Director, Faculy of Biomedical and Life Sciences, University of Glasgow
|
|
|
|
Florian Müllershausen, Laboratory Head Developmental & Molecular Pathways, Novartis
|
|
|
|
Kevin Pfleger, Research Associate Professor, Head of the Laboratory for Molecular Endocrinology - GPCRs, Western Australian Institute for Medical Research and Centre for Medical Researcg, University of Western Australia
|
|
|
|
Chris van Koppen, Director Molecular Pharmacology, Schering Plough
|
|
|
|
Ulrich Wendt, Director Structural Biology, Sanofi-Aventis
|
|
|
|
Keith Wreggett, Target Biology, Bioscience, AstraZeneca
|
|
|
|
|
|
|
|
Speakers
